Skvarka Jan 4
4 · Zentalis Pharmaceuticals, Inc. · Filed Feb 4, 2025
Insider Transaction Report
Form 4
Skvarka Jan
Director
Transactions
- Purchase
Common Stock
2025-01-31$1.72/sh+60,000$103,446→ 149,551 total
4 · Zentalis Pharmaceuticals, Inc. · Filed Feb 4, 2025
Common Stock